Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 52.51

+2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (1686)	9/18/2000 1:23:00 PM
From: Pseudo Biologist	Read Replies (1) of 52153

Wilder, on According to Barton, this ruling means that it will be possible to get a patent on an abstract procedure or an algorithm. And it will impact biotechnology. For instance, he continued, "We will quickly see patents on computational methods for calculating protein folding." According to Barton, "This case is saying that it's a lot harder to draw the line between the discovery of a scientific principle and the development of a patentable invention." People are trying this already (I mean patenting - looking for the algorithms has gone on for at least 25 years now): This deals with a potentially important "subproblem" in protein folding: patents.ibm.com This goes further (the method really does not work but what the heck): patents.ibm.com Another one that does not work: patents.ibm.com This is for going to sequence from 3D structure (backwards but useful - this one actually does work to some extent): patents.ibm.com An attempt from the mid 70's (of course, it does not work) ncbi.nlm.nih.gov Last, thanks for pointing us to the article, very interesting. PB

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next